Forget Mark Zuckerberg’s vision of VR meetings; the industrial metaverse bridges digital and physical worlds in a way that’s actually useful.
The Covid-19 pandemic showed just how vulnerable global supply chains are. Climate shocks could pose an even greater risk.
Long confined to the lab, humanoids finally appear ready to work in manufacturing. There are just a few hurdles to get them to market.
A massive blackout affecting Spain, Portugal, and parts of France has been blamed on atmospheric conditions. Now engineers face the arduous task of getting the power back on.
Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.
Workers who recently lost their jobs at the National Institute for Occupational Safety say they’re concerned that there’s no plan for managing biological samples tied to research projects.
The elective medical industry is cashing in on plastic pollution fears, but the evidence of harm from microplastics is still deeply uncertain.
DNA-testing company 23andMe has filed for bankruptcy, which means the future of the company’s vast trove of customer data is unknown. Here’s what that means for your genetic data.
Stardust, an Israeli–US startup, intends to patent its unique aerosol technology for temporarily cooling the planet.
Thousands of US Department of Agriculture employees, including food inspectors and disease-sniffing dog trainers, remain out of work, leaving food to rot in ports and pests to proliferate.